Trio-Tech International

Trio-Tech International is an engineering services company providing semiconductor testing, manufacturing, and real estate operations in Asia — not a biotech. Its RNA Therapy classification is a data mismatch. With 532 insider transactions, conviction in the semiconductor testing business is high from an insider perspective, but biotech signals are not applicable. Evaluate on semiconductor testing capacity utilization and Asian manufacturing services demand.

<article class="bts-verified-summary" data-ticker="TRT">
<p>Trio-Tech International Common Stock (TRT) has no currently recruiting or active clinical trials where it is listed as lead sponsor on ClinicalTrials.gov.</p>
<p>TRT has 1 Form 4 insider filing recorded at the SEC in the past 30 days<sup><a href="#fn-1">[1]</a></sup>.</p>
<section class="sources" data-nosnippet aria-label="Sources"><h3>Sources</h3><ol><li id="fn-1">SEC EDGAR · 0000732026 (2026-04-11) <a href="https://efts.sec.gov/LATEST/search-index?q=%22TRT%22&amp;forms=4&amp;dateRange=custom&amp;startdt=2026-03-12&amp;enddt=2026-04-11" rel="nofollow noopener noreferrer">↗</a></li></ol></section>
</article>